Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo-Reference-Cited by-同舟云学术

Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo

Published:2001-12 Issue:24 Volume:8 Page:1840-1846
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Skelly CL,Curi MA,Meyerson SL,Woo DH,Hari D,Vosicky JE,Advani SJ,Mauceri HJ,Glagov S,Roizman B,Weichselbaum RR,Schwartz LB

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301597.pdf

Reference41 articles.

1. Bourassa MG et al. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences Circ 1985 72 (Suppl. V): V–71–V78

2. Donaldson MC, Mannick JA, Whittemore AD . Causes of primary graft failure after in situ saphenous vein bypass grafting J Vasc Surg 1992 15: 113–120

3. Schwartz R, Holmes DJ, Topol E . The restenosis paradigm revisited: an alternative proposal for cellular mechanisms J Am Coll Cardiol 1992 20: 1284–1293

4. Clowes AW . Stenosis and restenosis: why are they so difficult to treat? Ann Surg 1995 222: II–IV

5. Svensson EC, Schwartz LB . Gene therapy for vascular disease Curr Opin Cardiol 1998 13: 369–374

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia;PLOS ONE;2015-07-01

2. Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEK;Gene Therapy;2012-03-15

3. Gene therapy to prevent occlusion of venous bypass grafts;Expert Review of Cardiovascular Therapy;2008-06

4. Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow;Proceedings of the National Academy of Sciences;2007-07-12

5. Gene delivery to vascular endothelium using chemical vectors: implications for cardiovascular gene therapy;Expert Opinion on Biological Therapy;2007-05